甲基-(4-硝基苯氧基)-丙氧基-巯基膦烷 | 1085-34-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 甲基-(4-硝基苯氧基)-丙氧基-巯基膦烷
• 中文别名: 膦酸-甲氧型-(4-硝基苯基)-丙酯
• 英文名称: O-Propyl-O-(p-nitrophenyl)-methylphosphonothionat
• 英文别名: Phosphonothioic acid, methyl-, O-(4-nitrophenyl) O-propyl ester；methyl-(4-nitrophenoxy)-propoxy-sulfanylidene-λ5-phosphane
• CAS: 1085-34-3
• 化学式: C₁₀H₁₄NO₄PS
• 分子量: 275.265
• InChiKey: CUONSTMEQBVTLL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  96.4
• 氢给体数：
  0
• 氢受体数：
  5

文献信息

• Cholinesterase Inhibitors
  申请人：Thompson Charles M.

  公开号：US20170197996A1

  公开（公告）日：2017-07-13

  The invention provides compounds that inhibit cholinesterases, such as acetylcholinesterase and butyrylcholinesterase. Such compounds are useful to prevent or treat exposure of a patient (e.g., a human) to an organophosphoric nerve agent (e.g., sarin and VX) or to treat a patient suffering from a neurodegenerative disorder such as Alzheimer's Disease or Lewy Body Dementia. The compounds are further useful as diagnostic tools for use in medical or research radiography (e.g., positron emission tomography) when synthesized with a radionuclide (e.g., [18F]. Synthetic schemes to produce such compounds are also provided.